𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Molecular basis of familial hypercholesterolemia in Brazil: Identification of seven novel LDLR gene mutations

✍ Scribed by Luis A. Salazar; Mario H. Hirata; Selma A. Cavalli; Edna R. Nakandakare; Neusa Forti; Jaime Diament; Sérgio D. Giannini; Marcelo C. Bertolami; Rosario D. C. Hirata

Publisher
John Wiley and Sons
Year
2002
Tongue
English
Weight
150 KB
Volume
19
Category
Article
ISSN
1059-7794

No coin nor oath required. For personal study only.

✦ Synopsis

Communicated by Mark H. Paalman

Low-density lipoprotein receptor (LDLR) gene mutations cause familial hypercholesterolemia (FH), one of the most common single gene disorders. The spectrum of LDLR mutations in Brazil is not known. The aim of this study was the characterization of LDLR mutations in 35 unrelated Brazilian patients with heterozygous FH. The promoter region, the 18 exons and the flanking intron sequences of the LDLR gene were screened by PCR-SSCP analysis and by DNA sequencing. In addition, we have screened the apolipoprotein B gene (APOB) for known mutations (R3500Q and R3531C) that cause Familial defective apo B-100 (FDB) by PCR-RFLP procedure. We found two nonsense (E92X and C371X) and six missense LDLR mutations (R236W, G322S, G352D, A370T, C675W and C677Y), that were previously described in FH patients from other populations. We also found five novel missense [G(-20)R, T476P, V503G, D580H and S652R] and two novel frame shift LDLR mutations (FsR757 and FsS828). Four patients were found to carry two different mutations in the LDLR gene: G352D and A370T (one patient), S652R and C675W (one patient) and T476P and V503G (two patients). APOB mutations were not found. These findings demonstrate that there is a broad spectrum of mutations in the LDLR gene in FH individuals from Brazil.

📜 SIMILAR VOLUMES

Molecular characterization of familial h
Molecular characterization of familial hypercholesterolemia in Spain: Identification of 39 novel and 77 recurrent mutations in LDLR
✍ Pilar Mozas; Sergio Castillo; Diego Tejedor; Gilberto Reyes; Rodrigo Alonso; Mig 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 65 KB 👁 1 views

Mutations in the low-density lipoprotein receptor (LDLR) gene cause familial hypercholesterolemia (FH), an autosomal dominant inherited disorder associated with an increased risk of premature atherosclerosis. The aim of this study was to characterize the LDLR mutations in a group of 476 apparently n

Molecular genetics of familial hyperchol
Molecular genetics of familial hypercholesterolemia in Spain: Ten novel LDLR mutations and population analysis
✍ Ana B. García-García; José T. Real; Oscar Puig; Elvira Cebolla; Pablo Marín-Garc 📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 English ⚖ 40 KB 👁 1 views

## Communicated by Mark H. Paalman Mutations underlying FH in Spain are largely unknown because only a few and limited surveys have been carried out on Spanish FH patients up to now. To gain information on this issue, we have analysed a group of 113 unrelated Spanish FH patients from an eastern ar

The molecular basis of familial hypercho
The molecular basis of familial hypercholesterolemia in Lebanon: Spectrum of LDLR mutations and role of PCSK9 as a modifier gene
✍ Marianne Abifadel; Jean-Pierre Rabès; Sélim Jambart; Georges Halaby; Marie-Hélèn 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 158 KB 👁 1 views

Autosomal dominant hypercholesterolemia (ADH), a major risk for coronary heart disease, is associated with mutations in the genes encoding the low-density lipoproteins receptor (LDLR), its ligand apolipoprotein B (APOB) or PCSK9 (Proprotein Convertase Subtilin Kexin 9). Familial hypercholesterolemia

Identification of recurrent and novel mu
Identification of recurrent and novel mutations in the LDL receptor gene in Japanese familial hypercholesterolemia
✍ Hiroaki Hattori; Makoto Nagano; Fujihiko Iwata; Yasuhiko Homma; Tohru Egashira; 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 19 KB 👁 2 views

We used the denaturing gradient gel electrophoresis (DGGE) method to investigate 120 Japanese patients with familial hypercholesterolemia (FH) for mutations in the promoter region and the 18 exons and their flanking intron sequence of the low density lipoprotein (LDL) receptor gene. Fourteen aberran

Identification of seven novel mutations
Identification of seven novel mutations in the GAN gene
✍ P. Bomont; C. Ioos; C. Yalcinkaya; R. Korinthenberg; JM. Vallat; S. Assami; A. M 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 31 KB 👁 1 views

Giant axonal neuropathy (GAN) is a severe early onset neurodegenerative disorder affecting both the peripheral nerves and the central nervous system. The diagnosis is based on the presence of characteristic giant axons on nerve biopsy. In GAN, the integrity of the intermediate filament network is al

Identification of recurrent and novel mu
Identification of recurrent and novel mutations in the LDL receptor gene in Spanish patients with familial hypercholesterolemia
✍ Ana Cenarro; Henrik K. Jensen; Elena Casao; Fernando Civeira; José González-Boni 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 46 KB 👁 2 views

We used the single strand conformation polymorphism (SSCP) method to investigate 13 apparently unrelated Spanish patients with familial hypercholesterolemia (FH) for mutations in the promoter region and the 18 exons and their flanking intron sequences of the low density lipoprotein (LDL) receptor ge